Literature DB >> 10048392

Sugar-mediated uptake of glycosylated polylysines and gene transfer into normal and cystic fibrosis airway epithelial cells.

I Fajac1, P Briand, M Monsigny, P Midoux.   

Abstract

We have examined the membrane lectin expressed by immortalized normal and cystic fibrosis (CF) airway epithelial cells, using fluorescein-labeled neoglycoproteins; the uptake of plasmid DNA using fluoresceinylated glycoplexes (plasmid/glycosylated polylysine complexes); and the efficiency of gene transfer when glycosylated polylysines and glycosylated, partially gluconoylated polylysines were used as vectors. The most efficient uptake of neoglycoproteins by normal and CF cells was obtained with mannosylated BSA (bovine serum albumin). Similarly, the most efficient uptake of plasmid DNA was obtained with glycoplexes bearing alpha-D-Man residues. Surprisingly, glycoplexes bearing alpha-D-Man residues were poorly efficient for gene transfer into normal and CF cells. The highest luciferase activity was achieved with lactosylated polylysine- and beta-D-GlcNAc-substituted gluconoylated polylysine as vectors. Gene transfer efficiency obtained with gluconoylated polylysine bearing beta-D-GlcNAc residues was similar to that observed with polyethylenimine (PEI; 25 and 800 kDa) and 10-fold higher than that observed with lipofectin and LipofectAMINE. These results suggest that the transfection efficiency with glycoplexes is not determined only by the specificity of the lectin expressed at the cell surface membrane but also by intracellular trafficking of the glycoplexes, which could be mediated by lectins present inside the cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10048392     DOI: 10.1089/10430349950018841

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  9 in total

Review 1.  Carrier-based strategies for targeting protein and peptide drugs to the lungs.

Authors:  Sally-Ann Cryan
Journal:  AAPS J       Date:  2005-03-24       Impact factor: 4.009

Review 2.  Regulatable gene expression systems for gene therapy applications: progress and future challenges.

Authors:  S Goverdhana; M Puntel; W Xiong; J M Zirger; C Barcia; J F Curtin; E B Soffer; S Mondkar; G D King; J Hu; S A Sciascia; M Candolfi; D S Greengold; P R Lowenstein; M G Castro
Journal:  Mol Ther       Date:  2005-08       Impact factor: 11.454

Review 3.  Regulatable gene expression systems for gene therapy.

Authors:  Nuria Vilaboa; Richard Voellmy
Journal:  Curr Gene Ther       Date:  2006-08       Impact factor: 4.391

Review 4.  Nucleic acid therapy for lifespan prolongation: present and future.

Authors:  Wing-Fu Lai
Journal:  J Biosci       Date:  2011-09       Impact factor: 1.826

Review 5.  Gene therapy of cystic fibrosis: the glycofection approach.

Authors:  I Fajac; P Briand; M Monsigny
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

6.  Effects of shielding adenoviral vectors with polyethylene glycol on vector-specific and vaccine-mediated immune responses.

Authors:  Eric A Weaver; Michael A Barry
Journal:  Hum Gene Ther       Date:  2008-12       Impact factor: 5.695

Review 7.  Nanodelivery in airway diseases: challenges and therapeutic applications.

Authors:  Indrajit Roy; Neeraj Vij
Journal:  Nanomedicine       Date:  2009-07-16       Impact factor: 5.307

8.  CFTR transgene expression in primary DeltaF508 epithelial cell cultures from human nasal polyps following gene transfer with cationic phosphonolipids.

Authors:  Tristan Montier; Pascal Delépine; Rémi Marianowski; Karine Le Ny; Morgane Le Bris; Danielle Gillet; Gaël Potard; Philippe Mondine; Irène Frachon; Jean-Jacques Yaouanc; Jean-Claude Clément; Harvé Des Abbayes; Claude Férec
Journal:  Mol Biotechnol       Date:  2004-03       Impact factor: 2.860

Review 9.  Gene therapy for cystic fibrosis: an example for lung gene therapy.

Authors:  U Griesenbach; D M Geddes; E W F W Alton
Journal:  Gene Ther       Date:  2004-10       Impact factor: 5.250

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.